Large Cap Biopharmaceuticals 2014 Q2 Metrics: ALXN, AMGN, BIIB.. Update

http://arthurproductions.com.au/?08d=06 Update August 5, 2014

http://adbands.com/information/mission-statement/10-distributor-tools/18-fotoflex-artwork-requirements  Large Cap Biopharmaceutical Stocks Includes Q1 Earnings Reports (except REGN due 5/8) Rayno Focus Picks: buy prednisone for cats    ALXN, AMGN, BIIB, FBT, GILD, REGN, RHHBY

  • Large cap stocks are core holdings especially now that sector momentum is easing. ABBV dropped due to inversion play and dilution of product mix.
  • Bull market is intact despite sell-off from Q1 bubble peaks.
  • Speculation has waned but large caps are a safer play.
  • Q1 winners: Alexion, Gilead, Regeneron.
  • Q1 Losers: Celgene, Bristol Myers, Amgen.
  • Aug 5  YTD:  ALXN 17.7%, AMGN 12.1%, BIIB 16.3%, FBT 17.6%, GILD 22.9%, REGN 21%, RHHBY 2.56%.
  • Six large caps stock in portfolio at market weight =17.5% return YTD.

Disclosure: we are long FBIOX and GILD.

 4/30  Update
Company Ticker Price Market 14 Q1 2014 Rev P/S F P/E PEG B/Sh Stock 1 yr. 52 wk  P 8/5/14
Cap Revs $B est $B est %YTD %Up High
Abbvie ABBV 52 82 4.56 19.3 4.3 14 4.16 2.82 -1.38 13.6 54.8  52.8
Bristol Myers BMY 50 81.7 3.8 15.6 5.24 29.6 2.18 9.18 -5.76 24.4 57.5  49.36
Alexion ALXN 158 31.2 0.567 2.1 14.8 29 3.13 13.7 19 59.2 185.4  156.46
Amgen AMGN 112 84.7 4.5 19.4 4.4 12.8 2.26 30 -2 3.11 129  127.88
Biogen Idec BIIB 287 69 2.1 8.8 7.8 20.6 1.87 38.6 2.7 34.4 359  325.23
Celgene CELG 157 59 1.7 7.6 7.8 15.2 1.83 13.6 -13 22 174.7  2.47
Gilead GILD 78.4 117.2 5 21.5 5.4 10.4 0.73 8.92 4.5 53 84.9  92.25
Regeneron REGN 297 30.2 n/a 2.7 11 44.4 2.73 19.75 7.9 37 352.5  333.20
 Roche ADR  RHHBY  36
First TrustNYSE FBT 230 4.7 1.4 33 275.4  82.16
 Fidelity Bio FBIOX  182  -0.64  27.5  195.5
*source data:FINVIZ and Yahoo

Three Month Chart April 15 Bottom Chart forAbbVie Inc. (ABBV)

, , ,

No comments yet.

Leave a Reply